Glatiramer acetate anaphylaxis: Detection of antibodies and basophil activation test

Journal of Investigational Allergology and Clinical Immunology

Volumn 22, Issue 1, 2012, Pages 65-66

  Soriano Gomis, V ^a,b   Perez Sempere A ^a   Gonzalez Delgado P ^a   Sempere, J M ^c   Niveiro Hernandez E ^a   Marco, Francisco M ^c,d  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c UNIVERSITY OF ALICANTE   (Spain)

^d Instituto de Inmunología y Alergia INMUNAL   (Spain)

Author keywords

Drug allergy; Glatiramer acetate; Multiple sclerosis

Indexed keywords

ADRENALIN; DEXCHLORPHENIRAMINE; GLATIRAMER; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; METHYLPREDNISOLONE;

ABDOMINAL CRAMP; ADULT; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BASOPHIL; CASE REPORT; DRUG WITHDRAWAL; DYSPNEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INJECTION SITE REACTION; MULTIPLE SCLEROSIS; PRICK TEST; PRURITUS; RISK FACTOR; SKIN TEST; SYNCOPE; TH1 CELL; TH2 CELL; UNCONSCIOUSNESS; URTICARIA; VOMITING;

ADULT; ANAPHYLAXIS; ANTIBODIES; BASOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PEPTIDES; SKIN TESTS;

EID: 84859180863     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Ruggieri M, Avolio C, Livrea P, Trojano M. Glatiramer acetate in multiple sclerosis: a review. CNS Drug Rev. 2007;13:178-91.
2. Sánchez-López J, Rodríguez del Rio P, Cases-Ortega B, Martínez-Cócera C, Fernández-Rivas M. Allergy workup in immediatetype local reactions to glatiramer acetate. J Investig Allergol Clin Immunol. 2010;20:521-3.
3. Ziemssen T, Neuhaus O, Hohlfeld R. Risk-benefi t assessment of glatiramer acetate in multiple sclerosis. Drug Saf. 2001;24:979-90.
4. Rauschka H, Farina C, Sator P, Gudek S, Breier F, Schmidbauer M. Severe anaphylactic reaction to glatiramer acetate with specifi c IgE. Neurology. 2005;64:1481-2.
5. Gamboa P, Sanz ML, Caballero MR, Urrutia I, Antépara I, Esparza R, de Weck AL. The fl ow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-infl ammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy. 2004;34:1448-57.
6. Farina C, Vargas V, Heydari N, Kümpfel T, Meinl E, Hohlfeld R. Treatment with glatiramer acetate induces specifi c IgG4 antibodies in multiple sclerosis patients. J Neuroimmunol. 2002;123(1-2):188-92.